Tremor in Parkinson disease: acute response to oral levodopa

Ital J Neurol Sci. 1990 Jun;11(3):259-63. doi: 10.1007/BF02333855.

Abstract

A single blind placebo-controlled study has been performed in order to investigate objectively the acute tremorolytic effect of oral L-Dopa in ten parkinsonians chronically treated with L-Dopa. Finger tremor was assessed by means of a computerized accelerometer method, at rest and during maintenance of a fixed posture. Both resting and postural tremor were significantly influenced by L-Dopa. An "acute test" with oral L-Dopa, especially when different tremor components are investigated, may be useful for identifying objectively parkinsonians whose tremor does not respond to drug therapy or shows a deterioration of drug-responsiveness.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Administration, Oral
  • Diagnosis, Computer-Assisted
  • Humans
  • Levodopa / therapeutic use*
  • Parkinson Disease / complications*
  • Parkinson Disease / drug therapy
  • Posture
  • Rest
  • Time Factors
  • Tremor / drug therapy
  • Tremor / etiology*
  • Tremor / physiopathology

Substances

  • Levodopa